The Company recorded restructuring charges of $0.2 million and $1.0 million during the three months ended December 31, 2025 and 2024, respectively. The Company recorded restructuring charges of $0.5 million and $2.3 million during the six months ended December 31, 2025 and 2024, respectively. These charges primarily included severance and benefits costs and professional fees as well as asset disposal costs related to the restructuring plans executed in prior years.

During the third quarter of fiscal 2024, the Company executed a global reduction-in-force plan targeted towards the reorganization of the Company's research and development and sales and marketing functions to align the Company's workforce with its strategic priorities and to focus on specific geographies and industry segments with higher growth opportunities (the “Q3 2024 Plan”). During the three months ended December 31, 2025, the Company did not record any restructuring charges related to the Q3 2024 Plan. During the six months ended December 31, 2025, the Company recorded restructuring charges of $0.4 million related to the Q3 2024 Plan, which primarily consisted of severance and benefits expenses, legal and consulting fees. During the three and six months ended December 31, 2024, the Company recorded restructuring charges of $0.9 million and $1.5 million, respectively, related to the Q3 2024 Plan. These charges primarily consisted of severance and benefits expenses, legal and consulting fees.

During the second quarter of fiscal 2024, the Company executed a global reduction-in-force plan to rebalance its workforce to create greater efficiency and improve execution, in alignment with the Company's business and strategic priorities, while reducing its ongoing operating expenses to address reduced revenue and macro-economic conditions (the “Q2 2024 Plan”). During the three and six months ended December 31, 2025, the Company recorded restructuring benefits of $0.1 million and $0.2 million, respectively, related to the Q2 2024 Plan, which primarily consisted of reversals of previously established accruals related to unused severance benefits. During the three and six months ended December 31, 2024, the Company recorded restructuring charges of less than $0.1 million and $0.6 million, respectively, related to the Q2 2024 Plan, which primarily consisted of severance and benefits expenses, legal and consulting fees.

Through December 31, 2025, the Company has incurred $28.6 million in restructuring charges under the Q2 2024 Plan and Q3 2024 Plan which primarily related to severance and benefits costs. As of December 31, 2025 these plans were substantially complete.

During the third quarter of fiscal 2023, the Company initiated a restructuring plan to transform its business infrastructure and reduce its facilities footprint and the facilities related charges (the “2023 Plan”). As part of this project, the Company moved engineering labs from its San Jose, California location to its Salem, New Hampshire location. This move is expected to help reduce the cost of operating the Company's labs. During the three and six months ended December 31, 2025, the Company recorded charges of $0.3 million for asset disposals related to the 2023 Plan. During the six months ended December 31, 2024, the Company recorded restructuring charges of approximately $0.1 million related to the 2023 Plan. As of December 31, 2025 this plan was complete.

Restructuring liabilities are recorded in “Other accrued liabilities” in the accompanying condensed consolidated balance sheets. As of December 31, 2025 and June 30, 2025, the restructuring liability was less than $0.1 million and $0.7 million, respectively, related to these restructuring plans.

The following table summarizes the activity related to the Company’s restructuring and related liabilities during the following periods (in thousands):


	Three Months Ended						Six Months Ended
	December 31, 2025			December 31, 2024			December 31, 2025			December 31, 2024
Balance at beginning of period	$	618		$	4,393		$	693		$	11,469
Period charges		—			1,134			437			2,707
Period reversals		(114	)		(97	)		(180	)		(393	)
Period payments		(436	)		(2,032	)		(882	)		(10,385	)
Balance at end of period	$	68		$	3,398		$	68		$	3,398